NCT02760238View on ClinicalTrials.gov

Myeloproliferative Neoplasms (MPNs) Patient Registry

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Primary MyelofibrosisPolycythemia VeraEssential ThrombocythemiaMastocytosisLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeLeukemia, Myelomonocytic, JuvenileChronic Eosinophilic Leukemia-not Otherwise SpecifiedMyelodysplastic-Myeloproliferative DiseasesNeoplasmsLeukemia, Myelomonocytic, Chronic
Interventions
OTHER

Observational

Trial Locations (1)

M5G 1Z5

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER